References
- Alavian, S.-M., 2006. Immunization: an important strategy to control hepatitis B. Hepatitis monthly, 6, 3–5.
- Alavian, S.M., et al., 2016. Recommendations for the clinical management of hepatitis C in Iran: a consensus-based national guideline. Hepatitis monthly, 16, e40959.
- Anwar, W.A., et al., 2008. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutation research/reviews in mutation research, 659, 176–184.
- Chen, C.-H., et al., 2007. Aflatoxin exposure and hepatitis C virus in advanced liver disease in a hepatitis C virus – endemic area in Taiwan. The American journal of tropical medicine and hygiene, 77, 747–752.
- Chu, Y.J., et al., 2017. Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers. International journal of cancer, 141, 711–720.
- El-Serag, H.B., 2012. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142, 1264–1273.
- Ferlay, J., et al., 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer, 127, 2893–2917.
- Gomaa, A.I., et al., 2008. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World journal of gastroenterology, 14, 4300–4308.
- Hesamizadeh, K., et al., 2016. Next steps toward eradication of hepatitis C in the era of direct acting antivirals. Hepatitis monthly, 16, e37089.
- Jamali, M., et al., 2013. Expression of aflatoxin genes aflO (omtB) and aflQ (ordA) differentiates levels of aflatoxin production by Aspergillus flavus strains from soils of pistachio orchards. Research in microbiology, 164, 293–299.
- Jee, S.H., et al., 2004. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. Journal of the national cancer institute, 96, 1851–1856.
- Kew, M.C., 2003. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver international, 23, 405–409.
- Kew, M.C., 2012. Hepatocellular carcinoma in developing countries: prevention, diagnosis and treatment. World journal of hepatology, 4, 99–104.
- Khoshpey, B., Farhud, D., and Zaini, F., 2011. Aflatoxins in Iran: nature, hazards and carcinogenicity. Iranian journal of public health, 40, 1.
- Lai, H., et al., 2014a. Association between aflatoxin B1 occupational airway exposure and risk of hepatocellular carcinoma: a case-control study. Tumour biology, 35, 9577.
- Lai, H., et al., 2014b. Association between aflatoxin B1 occupational airway exposure and risk of hepatocellular carcinoma: a case-control study. Tumor biology, 35, 9577–9584.
- Liu, Y. and Wu, F., 2010. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environmental health perspectives, 118, 818.
- Merat, S., et al., 2000. Hepatitis B in Iran. Archives of Iranian medicine, 3, 192–201.
- Moghaddam, S.D., et al., 2010. Incidence of hepatocellular carcinoma in southeast Iran. Hepatitis monthly, 10, 270.
- Razzaghi-Abyaneh, M., 2013. Aflatoxins: recent advances and future prospects. Rijeka, Croatia: InTech.
- Razzaghi-Abyaneh, M., et al., 2014. Global health issues of aflatoxins in food and agriculture: challenges and opportunities. Frontiers in microbiology, 5, 420.
- Saha, D., et al., 2007. Simultaneous enzyme immunoassay for the screening of aflatoxin B1 and ochratoxin A in chili samples. Analytica chimica acta, 584, 343–349.
- Turner, P., et al., 2000. Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Tropical medicine and international health, 5, 837–841.
- Verslype, C., Rosmorduc, O., and Rougier, P., 2012. Hepatocellular carcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 23, vii41–vii48.
- Williams, J.H., et al., 2004. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. The American journal of clinical nutrition, 80, 1106–1122.
- Wogan, G.N., Kensler, T.W., and Groopman, J.D., 2012. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review. Food additives & contaminants: part A, 29, 249–257.
- Yu, J., 2012. Current understanding on aflatoxin biosynthesis and future perspective in reducing aflatoxin contamination. Toxins (Basel), 4, 1024–1057.
- Zhang, Y.J., et al., 2006. Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients. International journal of cancer, 119, 985–991.